Integrated Diagnostics : Presentation for 1Q2021 results
June 14, 2021 at 03:03 pm IST
Share
IDH Results Presentation
June 2021
Contents:
IDH At a Glance
1Q 2021 Results Overview
Key Investment Highlights
Our Market
Our Business Model
Financial Position and Performance
Growth Strategies
Governance
Who We Are
Integrated Diagnostics Holding is a leading, fully-integrated provider of high-quality medical
diagnostic services with a footprint spanning Egypt, Jordan, Sudan and Nigeria
Our Services
Our Brands
Accreditations
Immunology Radiology Hematology
Endocrinology
Clinical
Molecular
Chemistry
Biology
Cytogenetics Histopathology Microbiology
+ 40 years
7 key brands
483
27.1 MN
Hena Holdings
Track record
With strong awareness
Branch labs as at 31 Mar. 2021
FY20 Tests
21%
EGP 2.7BN
Shareholding 54%
Ltd
+2,000
4
7.1 MN
Actis Idn B.V.
Structure
Free Float
Diagnostic tests
Country footprint (Egypt,
FY20 Patients
FY20 Revenues
Jordan, Sudan & Nigeria)
offered
26%
3 INTEGRATED DIAGNOSTICS HOLDINGS
Our Geography
IDH's branch network of 483 labs as at 31 March 2021 spans 4 countries, the largest of which is
Egypt
20
The Company's Egyptian
operations contributed
branches
82% of consolidated
revenues in 1Q 2021
Jordan
431
EGYPT
Branches
Egypt
81.5%
1979
Cairo Region
1Q 2021
49%
Upper Egypt Region
16%
JORDAN
Alexandria Region
Sudan
16.8%
2011
1Q 2021
9%
Delta Region
Nigeria
26%
SUDAN
0.6%
2011
12
1Q 2021
branches
20
NIGERIA
branches
1.1%
2018
1Q 2021
4 INTEGRATED DIAGNOSTICS HOLDINGS
Our Patients
IDH serves two principal types of patients: contract and walk-in
Around 70% of total revenue generated across the two segments is paid in cash
Contract Patients
Walk-In Patients
IDH's contract clients include institutions who enter into one-year renewable contracts at agreed rates per-testand on a per-clientbasis. Around 40% of the revenue generated by the segment is paid in cash. IDH's corporate clients roster currently features institutions such as:
Unions
IDH's walk-in clients, also referred to as "self-payers",pay out of pocket for diagnostic tests and other services.
Syndicates
Private and public insurance companies
Banks and corporations
Public institutions
Contribution to IDH Revenue (1Q 2021)
EGP
47% 1,130 53%
mn
Patient Split by Segment (1Q 2021)
34%
2.4 mn
patients
66%
Contract Revenues
Walk-in Revenues
Contract Patients
Walk-in Patients
5 INTEGRATED DIAGNOSTICS HOLDINGS
This is an excerpt of the original content. To continue reading it, access the original document here.
Attachments
Original document
Permalink
Disclaimer
IDH - Integrated Diagnostics Holdings plc published this content on 14 June 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 14 June 2021 09:32:01 UTC.
Integrated Diagnostics Holdings PLC is a consumer healthcare company. The Company operates in the Middle East and Africa with operations in Egypt, Jordan, Sudan and Nigeria. The Company is engaged in offering services in immunology, microbiology, hematology, endocrinology, clinical chemistry, molecular biology, histopathology, genetics, radiology and others. The Companyâs brands include Al Borg Scan, Al Mokhtabar, Ultralab, Biolab, Echo-Lab and others. It operates in approximately 552 branches. It offers more than 3,000 diagnostics tests ranging from routine to advanced. Its common tests include those for cholesterol, diabetes, pregnancy and substance abuse. Through Al Borg Scan, it offers a full range of radiology services, including magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography-computed tomography (PET-CT), electromyography (EMG), electrocardiogram (ECG), electroencephalogram (EEG), ultrasound, x-ray, mammograms and cath lab facilities.